Nonpharmacological treatments for anxiety disorders by Cottraux, Jean
onpharmacological treatments for anxiety dis-
orders—although of varied orientations—are unequally
represented in the literature.The bulk of the research is
devoted to behavior therapy (BT) and,more recently,to
cognitive therapy (CT) methods.Both CT and BT tech-
niques are used in combination by the vast majority of
clinicians and researchers under the label of cognitive
behavior therapy (CBT).Relaxation methods have been
used as the main technique in anxiety disorders or stud-
ied as a control condition in some randomized controlled
trials (RCTs).Some relaxation techniques,such as Ost’s
applied relaxation,
1-3 are in fact made of several cognitive
and behavioral techniques. Psychoanalytic (or psycho-
dynamic) therapies, hypnotherapy, Rogerian nondirec-
tive therapy,supportive therapy (ST),and psychological
debriefing for posttraumatic stress disorder (PTSD) have
been evaluated in RCTs and meta-analyses.Transcranial
neurostimulation and psychosurgery techniques have
been studied in obsessive-compulsive disorders (OCDs).
Some preliminary data exist for sympathectomy in
ereutophobia. Hence an evidence-based review of all
these nonpharmacological methods is possible.
Panic disorder and agoraphobia
CBT in panic disorder and agoraphobia
Panic disorder and agoraphobia are treated using two
basic strategies:exposure (in imagination and in vivo or
interoceptive exposure) and cognitive restructuring.
305
Clinical research
Nonpharmacological treatments for 
anxiety disorders
Jean Cottraux, MD, PhD
Keywords: anxiety disorder; meta-analysis; controlled trial; cognitive-behavior
therapy; psychological therapy; debriefing; psychosurgery
Author affiliations: Jean Cottraux, MD, PhD, Anxiety Disorder Unit, Hôpital
Neurologique, Lyon, France
Address for correspondence: Jean Cottraux, MD, PhD, Anxiety Disorder
Unit, Hôpital Neurologique, 59 boulevard Pinel, 69394, Lyon, France
(e-mail: cottraux@univ-lyon1.fr)
An evidence-based review of nonpharmacological treat-
ments for anxiety disorders is presented. The vast major-
ity of the controlled research is devoted to cognitive
behavior therapy (CBT) and shows its efficiency and
effectiveness in all the Diagnostic and Statistical Manual
of Mental Disorders, Fourth Edition (DSM-IV) anxiety
disorders in meta-analyses. Relaxation, psychoanalytic
therapies, Rogerian nondirective therapy, hypnotherapy,
and supportive therapy were examined in a few con-
trolled studies, which preclude any definite conclusion
about their effectiveness in specific phobias, agorapho-
bia, panic disorder, obsessive-compulsive disorder (OCD),
and posttraumatic stress disorder (PTSD). CBT was clearly
better than psychoanalytic therapy in generalized anx-
iety disorder (GAD) and performance anxiety. Psycho-
logical debriefing for PTSD appeared detrimental to the
patients in one high-quality meta-analysis. Uncontrolled
studies of psychosurgery techniques for intractable OCD
demonstrated a limited success and detrimental side
effects. The same was true for sympathectomy in ereu-
tophobia. Transcranial neurostimulation for OCD is
under preliminary study. The theoretical and practical
problems of CBT dissemination are discussed.
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Exposure principle
Exposure in vivo represents the final common pathway
of many techniques described by several schools of psy-
chotherapy.The first person to write a report on suc-
cessful exposure in agoraphobia was a French author,
Perroud
4 who was working at the Hôpital de la Charité,
in Lyon. Janet
5 used the exposure principle in several
cases of obsessions or phobias.Later,Freud
6 made a for-
gotten contribution to CBT with the straightforward
judgement that for resistant agoraphobia “one succeeds
only when one can induce them by the influence of the
analysis to go into the street and to struggle with their
anxiety.” In this respect, cognitive behavior therapists
are more Freudian than modern psychoanalysts, who
continue to treat agoraphobia with classic psycho-
analysis, while its effectiveness remains to be demon-
strated.
Wolpe
7 and Marks,
8 a fervent reader of Janet,systemat-
ically developed the exposure paradigm in anxiety dis-
orders and put this principle under systematic scientific
inquiry,in several controlled trials,which were replicated
all over the world.
Exposure consists in habituating degree by degree the
patient to the feared situations in imagination and then
in vivo.The aim is to obtain a habituation of emotional
responses and the extinction of avoidance behaviors,
which are reinforced by anxiety. Generally, the therapy
starts with exposure in imagination confronting the
patient step by step to the feared situations until habit-
uation occurs. Graded in vivo exposure is then carried
out. Each session of exposure in vivo or in imagination
may last up to 45 minutes,which is,in general,the max-
imum length of time required to habituate the anxiety
responses.
Cognitive restructuring
CT implements two main strategies:(i) cognitive restruc-
turing on misinterpretations of bodily sensations;and (ii)
breathing retraining in order to control the physiological
effects of hyperventilation and tachycardia.Treatment
typically includes 15 to 20 sessions, which can be sum-
marized as follows:
• Modifying panic attacks. (i) Breathing retraining to
control the sensations resulting from hyperventilation
frequently involved in panic attacks;(ii) Valsalva tech-
nique through abdominal breathing to control tachy-
cardia;and (iii) cognitive restructuring to modify mis-
interpretations of bodily sensations and challenge the
danger cognitive schemata.
• Modifying agoraphobia.Behavioral experiments con-
sist in modifying avoidance behaviors through graded
exposure followed by cognitive restructuring through
self-talk and written disputing on appropriate forms.
Interoceptive exposure for panic attacks
Some researchers designed specific techniques for the
bodily symptoms. Panic control treatment
9 consists of
three major strategies: (i) cognitive restructuring; (ii)
breathing retraining;and (iii) interoceptive or structured
exposure to bodily sensations that have become associ-
ated with panic attacks.
Since physical sensations often trigger conditioned anx-
iety, the procedure of interoceptive exposure attempts
to extinguish anxiety connected with these bodily sen-
sations.Identifying “interoceptive avoidance,”or avoid-
ance of situations that might provoke specific physical
sensations and their catastrophic cognitive appraisal, is
implemented during the therapy.These situations are
not identical to agoraphobic situations and may include
watching frightening movies or driving with the windows
closed.All patients are presented with exercises meant
to induce physical sensations:running on the spot,being
spun in a swivel chair,breathing through a narrow straw,
etc. Patients are then encouraged to enter naturalistic
situations that might be associated with the elicitation of
physical sensations that are particularly anxiety-pro-
voking.
Selected abbreviations and acronyms
BDZ benzodiazepine
BT behavior therapy 
CBT cognitive behavior therapy
CT cognitive therapy
EMDR eye movement desensitization and reprocessing
GAD generalized anxiety disorder
OCD obsessive-compulsive disorder
PTSD posttraumatic stress disorder
RCT randomized controlled trial
SSRI selective serotonin reuptake inhibitor
SST social skills training
ST supportive therapy307
Outcomes of exposure treatments
Meta-analyses on panic disorder
10-13 found that in vivo
exposure was a critical component of treatment,but dis-
agreed on its results in combination with antidepres-
sants, anxiolytic drugs, and cognitive interventions.Van
Balkom et al’s
13 meta-analysis and its follow-up study by
Bakker et al
14 suggested that the most effective treat-
ment was a combination of exposure in vivo and anti-
depressants. Another meta-analysis by Gould et al
15
found a higher size effect for CBT than for pharma-
cotherapy and a combination of medication with ther-
apy,with the lowest dropout rate and the best cost–effec-
tiveness ratio.Table I presents the outcomes of Gould et
al’s
15 meta analysis.Interoceptive exposure appears to be
the most effective technique.
Outcomes at follow-up
O’Sullivan and Marks
16 conducted a review of 10 long-
term follow-ups (the longest lasted 9 years). Four hun-
dred and forty-seven patients out of a panel of 553 had
been followed up in controlled studies for a mean dura-
tion of 4 years.They found a 76% improvement in the
cumulated samples with residual symptoms as a rule;
15% to 25% of the patients continued to have depres-
sive episodes after treatment. In the longer follow-ups,
up to 50% consulted practitioners for their psychologi-
cal problems and 25% saw psychiatrists for depression
and/or agoraphobia. However, the consultation rate
decreased.
CBT and medication:combination studies
Combination allows stopping the medication without
the very high relapse rate that is found in drug-only
studies. However, a positive interaction was found only
with certain antidepressant drugs (imipramine, fluvox-
amine,and paroxetine) and anxiolytic drugs (buspirone).
Moreover, CBT facilitates the withdrawal of benzodi-
azepines (BDZs).One may summarize the outcomes of
the combination studies as follows:
• Positive interactions with antidepressants were
reported in seven controlled studies.
17-23
• No interaction with antidepressants was found in five
studies.
24-28
• Short-term positive interaction and long-term negative
interaction of exposure in vivo with high doses of
alprazolam (6 mg) was found by Marks et al
29 and
Wardle et al.
30
• Short-term positive interaction of exposure in vivo
with low doses of diazepam (<30 mg) was found in a
controlled study.However,there was a transient with-
drawal syndrome.No negative long-term effects.
31
• Short-term positive interaction of CBT with low doses
of buspirone (<30 mg) on agoraphobia and general-
ized anxiety was demonstrated in a controlled study.
No withdrawal syndrome and no long-term negative
effects appeared.The effect of buspirone on agora-
phobia correlated with its effects on depressive cogni-
tion. Buspirone’s action on agoraphobic behaviors is
probably mediated by the reduction of both anxiety
and depression.
32
• CBT facilitated BDZ withdrawal in two controlled
studies.
33,34
Relaxation in panic disorder and agoraphobia
CT appeared to be superior to Jacobson’s relaxation in
one trial.
35 In a 2-year follow-up study,Craske et al
35 sug-
gested that Jacobson’s relaxation could even impede the
positive effects of BT.
Clark et al
36 found that CBT (84%) was superior to
relaxation (40%), imipramine with a maximum dose of
300 mg/day (42%), and a waiting list.The follow-up of
this study was 1 year.At this point,all intention-to-treat
groups received self-exposure instructions.This study
confirmed the superiority of CBT over relaxation and
also suggested that imipramine,the reference drug,was
neither the only effective treatment nor the most effi-
cient.
Applied relaxation
1-3 has been found to be as effective as
CBT in panic disorder with agoraphobia. However, it
contains cognitive coping strategies,as well as exposure
assignments.Accordingly,the applied relaxation format
is more a variant of CBT than a pure relaxation tech-
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Table I. Panic disorder: meta-analysis of size effects.
15 CT, cognitive ther-
apy; CBT, cognitive behavior therapy.
Therapy Size effect
CT + interoceptive exposure 0.88
CBT 0.68
Pharmacological treatment 0.47
Pharmacological treatment + CBT 0.56
Antidepressants 0.55
Benzodiazepines 0.40308
nique.This is confirmed by the fact that applied relax-
ation appeared better than Jacobson’s relaxation in one
controlled trial.
37 Nevertheless, applied relaxation was
superior to a waiting list, but inferior to CT in another
trial dealing with panic disorder without agoraphobia.
38
ST in panic disorder
In a controlled study,Beck et al
39 reported a rate of 71%
panic-free patients after 8 weeks of CT versus 25% after
8 weeks of ST.It is worth noting that 94% of the patients
who were randomized to ST chose to have CT after ST.
At a 1-year follow-up 87% of the patients who had CT
were panic-free versus 79% in the group who had ST
first and then CT. Beck et al’s
39 outcomes were at vari-
ance with those of Shear et al’s
40 controlled study,which
found at a 6-month follow-up that CT and ST demon-
strated positive and equivalent effects on panic attacks.
Psychodynamic therapy in panic disorder
To our knowledge, there is only one controlled study
concerning panic disorder.Wiborg and Dahl
41 compared
clomipramine alone with psychodynamic therapy (15
sessions) associated with clomipramine in 80 subjects
with panic disorder.Psychodynamic therapy was focused
on dependence behaviors and related emotional prob-
lems.The randomization process did not work in that
study:baseline Hamilton Anxiety,Hamilton Depression,
and Handicap scales were significantly higher in the
clomipramine group. Nevertheless, the authors con-
tended that the combined condition (20% relapses) was
superior to clomipramine alone (75% relapses) at a 9-
month follow-up.As there was no waiting-list control,
Wiborg et al’s
41 study does prove a specific effect of psy-
chodynamic therapy in panic disorder.
Generalized anxiety disorder
CBT in GAD
Methods
Since the first operational definition of generalized anx-
iety disorder (GAD) in the Diagnostic and Statistical
Manual of Mental Disorders,Third Edition (DSM-III),
42
the pathogenesis has been clearly concentrated on the
concept of excessive worry.
43This cognitive point of view
considers the somatic symptoms as secondary manifes-
tations of cognitive processes.Later,the DSM-IV
44 paid
allegiance to the cognitive model with another criterion:
the difficulty in controlling the worry.This new trend was
supported by numerous studies assessing normal and
abnormal thoughts showing the intolerance to uncer-
tainty of GAD subjects.Pathological worry is viewed as
shaped by cognitive distortions, which result from mal-
adaptive schemata of danger.Ruminations and attention
disturbances impede normal problem solving in every-
day situations and worry represents for the patient an
inefficient way to control possible negative events in the
future.
45
In CBT, the patient is advised to consider his or her 
catastrophic view up to its ultimate consequences.At this
point, Socratic questioning will help him or her substi-
tute more probabilistic views instead.The patient can
also be exposed in imagination to the catastrophic
scenes to reach habituation. Then, basic schemata of
danger are elicited and questioned.The treatment for-
mat classically involves about 15 sessions.The different
levels of intervention are cue-controlled relaxation,cog-
nitive restructuring,problem solving,in vivo exposure to
feared real-life situations, and exposure in imagination
in order to obtain habituation to highly improbable 
situations.The aim is to replace the worry by effective
coping strategies.
Outcomes
A meta-analysis by Gould et al
46,47 found CBT and phar-
macotherapy equally effective. This meta-analysis
included 35 controlled studies,which had been published
between 1974 and 1996: 13 studies dealt with CBT and
22 with medication.The size effect was 0.70 for CBT and
0.60 for the pharmacological treatment. However, the
drug samples had higher dropout rates and showed a
loss of efficacy at withdrawal, while the effects of CBT
were maintained. Studies assessing the CBT plus drug
combination were lacking.
Psychoanalytic therapy in GAD
Two studies reported negative outcomes for psychoan-
alytic therapies (Table II).
48-53 In Durham et al’s
48 study
psychoanalytic therapy had within-group positive effects,
but these effects were significantly inferior to those of
CBT immediately after the test and at 1-year follow-up.
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One should also mention that the psychoanalytic method
used by White
49 was less than optimal.
Rogerian nondirective therapy in GAD
Two studies reported equal effects of Rogerian therapy
and CBT.Two reported a better effect of CBT.Further
studies should be done to clarify this point.Table II also
presents the outcomes of these four studies.
50-53
Posttraumatic stress disorder
CBT in PTSD
Methods
Treatment of PTSD is the center of a growing interest in
the literature.Therapeutic programs involve relaxation,
which is beneficial in case of high emotional arousal,
exposure to avoided situations or images related to the
trauma, and CT. Five methods have been proposed.All
the methods insist on the necessity of respecting the
pace of the patient to reach the peak of the horror that
is at the center of the traumatic experience.
• Systematic desensitization presents the feared stimuli
in imagination under relaxation in a graded way prior
to in vivo exposure.
• Exposure in imagination and in vivo aims at habituat-
ing the patient to the aversive stimulus, by reducing
abnormal reactivity and avoidance. In vivo exposure
to the nondangerous situations being avoided is then
suggested.
• Stress management emphasizes the development of
coping strategies to deal with fears (relaxation, social
skills training [SST], modification of anxious verbal-
ization,or thought stopping).
• Cognitive therapy also suggests exposure in imagina-
tion and representation of coping strategies, but puts
a greater emphasis on dealing with automatic thoughts
and dysfunctional attitudes (personalization,guilt,illu-
sion of a safe world,and necessity of revenge).
• Eye movement desensitization and reprocessing
(EMDR) consists in inducing eye movements when
concentrated on feared imagery,bodily sensations,and
negative statements associated with the trauma, in
order to reduce anxiety and hence modify cognition in
a positive way.
54 Sessions last 90 minutes and are lim-
ited to 4 or 5.This method was hypothesized to work
on neuropsychological functions. In fact, there is no
clear evidence that EMDR is no more than a variant
of the usual CBT programs.A controlled study
55 found
that EMDR with or without ocular movements gave
the same positive outcomes as a standard psychiatric
procedure at posttest and a 6-month follow-up.
Nonspecific factors might be implied in EMDR.
Outcomes:meta-analysis
Most of the studies showed positive results.There is no
difference in outcomes between CT and BT.
56 About
60% of patients respond to the treatment. Follow-up
studies seldom exceed 6 months or 1 year.
Van Etten and Taylor
57 conducted a meta-analysis of 61
treatment outcome trials for PTSD.Treatments included
drug therapies (tricyclic antidepressants,carbamazepine,
monoamine oxidase inhibitors,selective serotonin reup-
take inhibitors [SSRIs],and BDZs),psychological ther-
apies (BT,EMDR,relaxation training,hypnotherapy,and
psychodynamic therapy), and control conditions (pill
placebo,waiting-list controls,supportive psychotherapies,
and nonsaccade EMDR control).Psychological therapies
demonstrated significantly lower dropout rates than
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Table II. Generalized anxiety disorder: cognitive behavior therapy (CBT) versus other therapies. ST, supportive therapy.
Outcome Duration of Reference
follow-up
• CBT versus psychoanalytic therapy
CBT > psychoanalytic therapy 1 year Durham et al,
48 1994
CBT > psychoanalytic therapy White et al,
49 1992
• CBT versus Rogerian nondirective therapy
CBT > ST 6 months and 1 year Borkovec and Mathews,
50 1987
CBT > ST 1 year Borkovec and Costello,
51 1993
CBT = ST 6 months Blowers et al,
52 1987
CBT = ST 6 months Stanley et al,
53 1996Clinical research
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pharmacotherapies (14% versus 32%).The attrition rate
was uniformly low.Follow-up results were only available
for BT and EMDR:outcome was maintained at 15-week
follow-up.
Psychodynamic therapy and hypnotherapy in PTSD
Brom et al’s
58 randomized study compared systematic
desensitization with psychodynamic therapy, hyp-
notherapy,and a waiting-list control in 112 patients.The
results showed a reduction in symptoms in all three
groups at posttest: improvement rate was 41% for sys-
tematic desensitization,34% for hypnotherapy,and 29%
for psychodynamic therapy.The between-group differ-
ence was nonsignificant.The study had no follow-up.
Debriefing for PTSD prevention
DSM-IV
44 considers that 1 month of stress reaction is
required to make a diagnosis of acute PTSD, and 6
months for chronic PTSD.Many subjects present spon-
taneous remissions in the 1-month interval following the
trauma. Debriefing was introduced by Mitchell
59 as a
short-term early intervention, which takes place in the
immediate aftermath of the trauma (within 48 h).The
aim is to reduce immediate posttraumatic distress and
to prevent PTSD occurring through discussing and reliv-
ing the traumatic event step by step.Debriefing consists
of a single group or individual session that lasts 3 h.
Typically, seven stages are implemented by a psycholo-
gist or in some cases by laypersons in a didactic format
that progressively reaches the emotional core of the
trauma:“introduction,”“facts,”“thoughts,”“reactions,”
“symptoms,”“teaching,”and “relating.”
Debriefing has been strongly advocated and widely
used in many countries, but well-designed evaluative
studies come out with negative outcomes. A meta-
analysis of 11 high-quality RCTs was carried out
60 and
found that single-session debriefing did not reduce dis-
tress,depression,or anxiety,and did not prevent PTSD
from occurring.Moreover,the risk of developing PTSD
was higher in those patients who received debriefing,
compared with those who did not, in one important
trial. In conclusion, the authors stated that compulsory
debriefing should cease. It seems that debriefing sensi-
tizes the patients, rather than enhancing habituation
process. It may also represent a second trauma that
“prints” the event in the autobiographical memory.
Patients with ruminations seem more likely to have
negative reactions.
Obsessive-compulsive disorder
CBT in OCD
Methods
The main behavioral strategy is in vivo exposure with
response prevention, which was initiated by Janet
5 and
developed by Meyer
61 and Marks.
8 Exposure with
response prevention means that exposure is carried out
while compulsions are not allowed to the patient.The
aim is to reach habituation to obsession-triggering stim-
uli.Nonetheless,it is less time-consuming and very cost-
effective to give homework assignments, which are
agreed on with the patient. It is also helpful to involve
the patient’s partner as a cotherapist. For patients for
whom the trigger is more internal, eg, fear of internal
representation rather than environmental cues or hav-
ing covert rituals, prolonged exposure in imagination is
the recommended procedure.
A cognitive behavioral model for OCD was proposed by
Salkovskis.
62 First, the intrusive thought, which is unac-
ceptable and egodystonic, is viewed as a “normal”
process failing to habituate for biological and/or psy-
chological reasons.Second,the obsessive thought (auto-
matic thought) is an evaluation of the intrusive ideas
through overresponsibility schemata deep-seated in the
long-term memory.This leads to rituals (overt behavior)
and neutralizing thoughts (covert behavior), which re-
presents an attempt to control and suppress intrusive
thoughts. Such neutralizations prevent habituation to
intrusive thoughts from occurring. Hence, Salkovskis
proposed a triple intervention: cognitive exposure to
intrusive thoughts with neutralization prevention,
Socratic questioning of the automatic thoughts and over-
responsibility schemata,followed by behavioral experi-
ments (in vivo exposure) to disconfirm the schemata.
Treatment classically involves 20 to 25 sessions.
Results of BT
BT has been clearly demonstrated to be superior to
placebo and relaxation.The outcome with BT is close to
that of serotonergic antidepressants, which have detri-
mental side effects and a high relapse rate after with-Nonpharmacological treatments for anxiety disorders - Cottraux Dialogues in Clinical Neuroscience - Vol 4 . No.3 . 2002
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drawal.
8 The limitations of BT could be summed up as
follows:dropout or refusals 25%;no or poor effect 25%;
and relapse 20% (3 months to 3 years).The controlled
studies combining BT with antidepressants show a bet-
ter outcome on rituals and depression in the long term.
In particular,Cottraux et al
63,64 showed fluvoxamine plus
BT compared with placebo plus BT to give better results
at 3 months on rituals and at 6 months on depression
with equivalent results at 12 and 18 months.The out-
comes of the combination studies are summarized in
Table III.
63-70
Table III. Obsessive-compulsive disorder: exposure with response prevention and antidepressants. A, anti-exposure; CBT, cognitive behavior therapy;
CMI, clomipramine; E, exposure; FLUOX, fluoxetine; FLV, fluvoxamine; IMI, imipramine; WL, waiting list; PET: positron emission tomography;
PBO, placebo; R, relaxation.
Study Patients Hamilton Depression Outcome
(n) Scale (17 items)
Solyom and Sookmann,
65 1977 27 • Short term (6 weeks)
CMI = imaginal flooding (ruminations)
CMI > thought stopping (ruminations)
CMI < E (rituals)
Marks et al,
66 1980 40 17 • Short term (7 weeks)
CMI + E > CMI + R
37 • Long term (2 years) 
CMI + E > PBO + E
at weeks 7 to 18, waning at week 36
Marks et al,
67 1988 49 10 • Short term (17 weeks)
CMI + E >> CMI + A
39 • Long term (2 years)
CMI + E > PBO + E
at week 8, waning at week 17
Cottraux et al,
63 1990 60 19 • Short term (8 weeks)
FLV + E or FLV > PBO + E (rituals)
44 • Mid term (24 weeks)
FLV + E or FLV > PBO + E (depression)
37 • Long term (1 year)
FLV + E = PBO + E = FLV
Cottraux et al,
64 1993 33 • Long term (18 months)
FLV + E = PBO + E = FLV
• Still under antidepressants
PBO + E and FLV + E = 18%
versus FLV = 60% (P<0.05)
Foa et al,
68 1992 19 20 • Short term (6 weeks)
IMI > PBO (depression)
• Long term (2 years)
19 11 IMI + E = PBO + E
19 20 IMI + E = PBO + E
Baxter et al,
69 1992 18 9 • Short term (10 weeks)
FLUOX = E on symptoms and reduction of  
right caudate hypermetabolism (PET)
Van Balkom,
70 1994 104 • Short term
FLV = CBT > WL (rituals) 
CBT > FLV > WL (anxiety)Long-term follow-up of CBT
When addressing the long-term follow-up question,
O’Sullivan and Marks
16 reviewed 9 cohorts of patients
over 1 to 6 years (mean of 3 years). They found 9%
dropout and 78% improvement, with a 60% mean
reduction in rituals. Nonetheless, residual symptoms
were a rule and liability for depression remained
unchanged.
Meta-analysis of CBT
Now that BT is firmly established, several meta-analy-
ses have been carried out. The latest meta-analysis
71
included 77 studies with 4651 patients and showed that
BT was superior to SSRI antidepressants as a class.
Nevertheless, this difference should be taken with cau-
tion as BT is limited by the problem of availability,
accessibility,and third-party payment in many countries.
CT in OCD
The status of CT is still under investigation and there
have recently been some new studies published (Table
IV).
72-79To date,the usefulness of CT for OCD has been
assessed in 8 controlled studies. Emmelkamp et al
72 did
not find a superior effect when adding cognitive modifi-
cations to in vivo exposure. Nevertheless, the design of
the experiment aimed at teaching the patient to replace
negative thoughts by positive ones.This could have been
used as neutralizing thoughts. Emmelkamp et al
73 com-
pared CT without exposure to self-managed exposure.
Six months after the end of treatment, both groups
showed equivalent reduction in rituals,generalized anx-
iety,and social anxiety.Only the cognitive group showed
change on the measures of depression.In a study with a
more impaired population, Emmelkamp and Beens
74
found similar results at a 6-month follow-up.Van Oppen
et al
75 randomized 71 patients in either Beckian CT or
exposure.After 16 sessions, they found a superiority of
cognitive interventions over exposure. Danger sche-
mata were better modified by CT than with exposure.
Unfortunately,this study had no long-term follow-up.A
multicentered study (76) compared CT with intensive
BT. Sixty-five ambulatory patients with DSM-IV OCD
and without major depression were randomized into two
groups for a 16-week psychological treatment:either CT,
or exposure and response prevention, for a 4-week
intensive treatment period followed by a maintenance
phase of 12 weeks. No medication was prescribed.At
week 16,the rates of responders were comparable in the
two groups.Depression (bipolar type I) was significantly
more improved in the group that received CT.At weeks
26 and 52, improvement was retained in both groups
without a between-group difference.Cognitive measures
of obsessions changed equally in the two groups.This
study replicated on a larger scale the findings of
Emmelkamp and coworkers.
73,74
Freeston et al
77 presented a study comparing a waiting
list with a group treated with CBT. In a group of OCD
312
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Table IV. Cognitive therapy (CT) in obsessive-compulsive disorder: controlled studies. BT, behavior therapy; CBT: cognitive behavior therapy; ERP: expo-
sure and response prevention; SSRI, selective serotonin reuptake inhibitor.
Study Outcome
• CT versus BT (ERP)
Emmelkamp et al,
72 1980 Self-instructional training + ERP = ERP (follow-up 6 months)
Emmelkamp et al,
73 1988 CT = ERP on rituals
CT > ERP on depression (follow-up 6 months)
Emmelkamp and Beens,
74 1991 CT = ERP (follow-up 6 months)
Van Oppen et al,
75 1995 CT > ERP (posttest)
Cottraux et al,
76 2001 CT = ERP on rituals 
CT > ERP on depression (posttest)
• Comparison with a waiting list
Freeston et al,
77 1997 In pure obsessions: CBT > waiting list (follow-up 6 months)
Jones and Menzies,
78 1998 CT > waiting list at posttest only. No difference at 3-month follow-up
• Comparison with SSRI (fluvoxamine antidepressant)
Van Balkom et al,
79 1998 ERP, CT, or SSRI combined with ERP or CT: same positive outcomes at 16 weeks 
Active treatments better than a waiting list at week 8patients with exclusively covert rituals, that the superi-
ority of CBT over the waiting list was maintained at 6
months’ follow-up. Jones and Menzies
78 found that CT
was superior to a waiting list at posttest only. Only one
study dealt with the problem of combination of CBT
with SSRI fluvoxamine
79 and found no difference
between active conditions (Table IV).
In conclusion, although there is still is a clear need for
more controlled studies,there is good evidence in favor
of a positive effect for the cognitive approach in OCD.
Psychodynamic therapy for OCD
There is a dearth of controlled data in this field. An
uncontrolled study by Kringlen
80 found that 20% of
OCD patients improve during an interval ranging from
13 to 20 years versus 21% of the patients treated with
psychoanalytic therapy during the same interval.
Psychosurgery
Since the introduction of prefrontal leukotomy by
Moniz,
81 several techniques have been developed:
stereotactic leukotomy,stereotactic cingulotomy,
68,69 and
the gamma-knife radiosurgery technique of capsulotomy.
In general, the orbitofrontal and cingulate regions are
the targets for intervention.
82 However, the literature
only reports series of uncontrolled case studies.About
25% of a panel of 33 patients who presented an
intractable OCD responded in the long term.
83The side
effects are severe—epilepsy, personality disorders, and
depression—and there have been cases of suicide.
84-86
Even the gamma-knife,which was supposed to be more
precise and safer, presented detrimental effects in the
form of extensive local brain necrosis after irradiation.
87
There is obviously a lack of scientific evidence for a
durable effect of these techniques in a sizeable number
of severe patients. Ethical problems, low effectiveness,
and side effects explain why psychosurgical decisions are
under the control of ethical committees in most of the
countries.
Transcranial stimulation
There is quite limited preliminary evidence that repeti-
tive transcranial magnetic stimulation of prefrontal areas
may improve compulsive urges, which were increased
after midoccipital stimulations.
88There was no difference
between right and left brain prefrontal stimulations.
89
These experiments were uncontrolled carried out in
severe OCD.A positive transient response was found in
only 25% of patients.
Social phobia
CBT in social phobia
Methods
Early behavioral interventions were based either on sys-
tematic desensitization or assertiveness training. Social
skills deficit was hypothesized as being at the core of
performance anxiety and social phobia. SST through
role play with rehearsal, shaping, and modeling by the
therapist was shown to be effective in treating social
phobic patients in the early seventies.
A move towards a cognitive model was the next step.
According to the cognitive model of social phobia,
90 cog-
nitive factors may be particularly important in the devel-
opment and maintenance of the negative emotions and
avoidance behaviors in social phobic patients. The
patients assume that other people are inherently critical,
and attach particular importance to being negatively
appraised by others.This could be related to a basic cog-
nitive schema of inferiority.
91 CT consists in identifying
negative automatic thoughts and schemata, and then
modifying them by more realistic interpretations.
Current therapeutic models tend to mix cognitive and
behavioral methods.The patient’s evidence for his or her
negative belief is cognitively questioned, but emphasis
is also put on behavioral experiments to test the irra-
tional assumptions.Treatment classically involves about
15 to 20 sessions in individual and/or group.
Outcomes 
The effectiveness of BT on various types of social anxi-
ety has been demonstrated in several controlled trials.
Social phobia, as such, attracted the interest of clinical
researchers after its inclusion in DSM-III,
42-44 and was
studied in controlled trials of SST, systematic desensiti-
zation, and in vivo exposure.
92,93 CT, too, demonstrated
its effectiveness in studies using waiting list or other
therapies as control.
94-96 Two studies reported some
advantages of CT combined with exposure over expo-
sure alone,
97,98 while one did not.
99 Another study
100
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found, in a mixed sample of socially inadequate and
phobic patients, that role playing and exposure were
superior to cognitive restructuring at a 6-month follow-
up.
Some researchers noticed that the gains of exposure
therapy were often limited by the negative influence of
cognitive factors that impeded anxiety reduction.
101 To
deal with this problem, a study
102 designed a Cognitive
Behavioral Group Treatment (CBGT),which was com-
pared with a credible placebo: lectures and ST.At a 6-
month follow-up, CBGT demonstrated clearly higher
effects: 75% of the patients in CBGT were improved
versus 40% of those in ST.This was confirmed in follow-
ups ranging between 4 and 6 years.
103
A dismantling study
104 comparing CBGT with exposure
found that each of the two methods was superior to a
waiting list,with a slight advantage of exposure over CT
on some measures.The rate of responders was not sta-
tistically different in the two active conditions.
Surprisingly,there was no greater improvement on cog-
nitive measures in the CBGT group.At a 6-month fol-
low-up there was no longer any between-group differ-
ence.
Another trial
105 showed, in limited social phobias, that
CT followed by exposure, exposure followed by CT, or
the combination of both had the same positive effects
without significant difference at a 3-month follow-up.
The same authors
106 demonstrated that CT followed by
exposure was better than their combination or exposure
followed by CT in generalized social phobia, at a 3-
month follow-up.
A meta-analysis
107 of 12 CBT and 9 exposure studies
concluded that CBT did not yield better outcomes than
exposure therapy,on self-report measures of social anx-
iety, cognitive symptoms, and depressed/anxious mood,
at posttest and follow-up.
Another meta-analysis
108 included 42 treatment outcome
trials and tested 6 conditions:waiting list,placebo,expo-
sure, CT, CT plus exposure, and SST.All the interven-
tions,including placebo,produced larger effect sizes than
a waiting list and did not differ in dropout proportions
(12% to 18%).However,only CT associated with expo-
sure yielded an effect size that was larger than placebo
(1.06 versus 0.48, respectively). Exposure alone had an
effect size of 0.81,nonsignificantly different from placebo.
Effect sizes tended to improve at follow-ups.
CBT effectiveness was confirmed by Gould’s meta-
analysis
109 in which pharmacotherapy (11 studies) had an
effect size of 0.62 versus placebo,while CBT (16 studies)
reached 0.74 compared with control conditions.
In summary, meta-analytic approaches of the research
suggest that CBT is effective and exposure is a crucial
component of CBT, while the effect of CT remains in
discussion.
Medication and CBT in social phobia
Main outcome studies
Buspirone was less effective than CBT at 6 weeks in
reducing performance anxiety in musicians.
110 Gelernter
et al
111 compared four groups:CBT,phenelzine,alprazo-
lam,and placebo.All four groups received instruction of
self-exposure. All groups improved significantly at 2
months with few differences between them. However,
this equal improvement could have resulted from the
exposure instructions. BT was superior to atenolol at 3
and 6 months.
112 A positive combination of exposure
with sertraline was found at 24 weeks.Combination was
superior to placebo,but equal to sertraline alone.
113 Few
differences,but in favor of clonazepam,were found in a
comparison of this BDZ with behavioral group ther-
apy
114;patients were only rated at 4,8,and 12 weeks.
CBGT was found to be superior to pill-placebo and edu-
cational group therapy,but slightly inferior to phenelzine
on some measures at the 12 weeks’ evaluation in a ran-
domized trial.
115 Follow-up data found that, after with-
drawal of the medication, CBGT was better, especially
in generalized social phobia.
116
Meta-analysis of CBT and medication
A meta-analysis
117 of psychological and pharmacological
treatments for social phobia was conducted: 108 treat-
ment-outcome trials were entered in this meta-analysis.
Eleven treatment conditions were compared:waiting-
list control, pill placebo, BDZ, SSRIs, monoamine oxi-
dase inhibitors, attention placebo, exposure, cognitive
restructuring, and applied relaxation.The most consis-
tently effective treatments for social phobias were phar-
macotherapies. BDZs and SSRIs were equally more
effective than control conditions. Dropout rates were
similar among all the active treatment conditions.The
durability of treatment gains for pharmacotherapies was
not assessed because of an insufficient number of drug
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CBT, although moderate, continued during the follow-
up period.BDZs and SSRIs seem to be effective treat-
ments for social phobia, at least in the short term.The
authors recommended assessment of the long-term out-
come and evaluation of the inclusion of a CBT during
the drug-tapering period.
Psychoanalytic therapies in performance anxiety
A randomized study by Paul
118 in 1966 in students with
lack of social skills and a fear of speaking in public
showed the superiority of systematic desensitization
over a control (attention-placebo) and psychodynamic
therapy at a 2-year follow-up. Psychodynamic therapy
demonstrated no better outcomes than the waiting list.
Although the study recruited a sample of students and
the DSM criteria for social phobia were not used in
those days, Paul’s
118 study suggests a significant positive
effect of systematic desensitization, and a lack of effec-
tiveness of psychodynamic therapy,in performance anx-
iety.
Supportive therapy 
One trial
119 dealt with a comparison of ST with CBT.The
aim of the trial was to study the effectiveness of CBT
versus ST carried out “as usual.” Sixty-seven DSM-IV
social phobic patients were randomly allocated into two
groups.Group 1 (CBT) received eight 1-hour sessions of
individual CT for 6 weeks, followed by six 2-hour ses-
sions of SST in group weekly. Group 2 received ST for
12 weeks (six 30-minute sessions),and then the patients
were switched to CBT. No medication was prescribed.
At week 6,after CT,group 1 was better than group 2 on
the main social phobia measure.At week 12, after SST,
group 1 was better than group 2 on most of the measures
and demonstrated a significantly higher rate of respon-
ders.This finding was replicated after switching group 2
to CBT. Sustained improvement was observed in both
groups at follow-up. In summary, CBT was more effec-
tive than ST and had long-lasting effects.
Sympathectomy for ereuthophobia
Endothoracic sympathectomy has been carried out for
the fear of blushing
120 with a questionable rationale
assuming that emotional response is mainly a peripheral
problem.
121 Despite early claims of high rate of success,
follow-up studies were less optimistic:67% of the patients
had compensatory sweating,50% gustatory sweating,and
Horner’s syndrome in 2.5%.Moreover,the number of ini-
tially satisfied patients declined over time from 98% to
66%.
122The survey was made through a simple question-
naire.There was no control group.It is obvious that this
is not a treatment of choice for an anxiety problem related
to a fear of blushing,more than to real blushing.
Specific phobias
CBT methods for specific phobias
Simple phobia is often considered as a normal fear,like
the fear of animals or of blood. Nevertheless, it affects
7% of the general population.In some cases,anxiety and
avoidance behaviors become a handicap severe enough
to lead to consultation.Treatment classically involves
about 10 to 15 sessions of exposure and imagination
and/or in vivo and cognitive restructuring.
Outcomes 
There is a lack of controlled studies.In many controlled
trials,simple phobias are often part of mixed samples of
phobic patients. Follow-up studies showed a 54%
improvement from baseline,which is maintained at fol-
low-up ranging from 1 to 5 years with BT.
16 Early con-
trolled studies of CT showed negative results.
123,124A study
by Getka and Glass
125 compared four groups for dentist
phobia:systematic desensitization,CT and stress man-
agement, interview with a warm practitioner prior to
intervention,and waiting list.At 1-year follow-up,BT and
CT produced equivalent results and were superior to the
two other conditions,but this needs more investigation.
Virtual reality was introduced as a tool to expose height
and flying phobias with positive results in a controlled
study of low statistical power.
126To summarize,despite a
scarce literature,in vivo exposure seems the treatment of
choice for simple phobia,
127 while pharmacology has not
been demonstrated to have positive effects.
128
Conclusion
This review shows that CBT has been proven to be
effective in all the DSM-IV categories of anxiety disor-
ders,in numerous RCT and several meta-analyses.Other
forms of psychotherapy either have not been tested, orgenerally have lesser effects than CBT in RCTs.Surgical
approaches proposed for OCD and ereuthophobia are
of limited value and may have detrimental side effects,
without mentioning their lack of scientific evidence.
However, some words of caution may temperate this
positive picture of CBT for anxiety disorders.
The cost-containment issues led the procedures to
become increasingly simplified. Some attempts have
been made to turn many techniques into self-help pro-
cedures,or computer-assisted therapy,or therapy admin-
istered by nurses, social workers, counselors, priests, or
lay people,using treatment manuals.However,manual-
ized therapies have limitations,especially when the ther-
apists are facing patients with multiple DSMAxis I and
Axis II problems.Those patients represent at least 50%
of the referrals in anxiety disorder units.There is obvi-
ously a limit to simplification: computer-administered
treatment appeared less effective than therapist-admin-
istered treatment in OCD.
129
There are no conflicting issues between biological and
psychological theoretical explanations. In practice, the
combination of CBT with antidepressants has been
shown to be effective in panic disorder and OCD.
However, theories and practice may be in competition.
CBT,due to the limited number of practitioners,even in
developed countries,can be difficult to find.One of the
reasons for this limited accessibility rests on the reduced
CBT training opportunities in the faculties of medicine
and psychology in many countries. Medication is easier
to administer,hence it tends to be the first line of inter-
vention, despite the demonstrated efficacy and long-
term effectiveness of CBT, and the fact that after stop-
ping medication most of the patients relapse while the
outcomes of CBT are stable.In the long-term,CBT costs
less than medication,as it prevents relapses from occur-
ring,as shown by cost-effectiveness surveys.
130
Another stumbling block is the gap between basic
research and practice.CBT practice is far ahead of theo-
retical explanations.Since the adoption of empiricism in
the study of normal and abnormal psychology,we should
note that the interest in fundamental psychology has
tended to fade away.The first behaviorists relied heav-
ily on basic research works, but the gap between prac-
tice and basic sciences has grown larger.
Marks
131 recently pointed out that,as far as clinical effec-
tiveness and efficiency are concerned,CBT is coming of
age,but it is a toddler in terms of the scientific explana-
tions of its effects. Historically, CBT was the first evi-
dence-based treatment for anxiety disorders,long before
evidence-based medicine was a bandwagon,
132 but now
needs to be more empirically grounded. Filling this gap
will be the endeavor of the 21st century researchers ded-
icated to the psychological approaches to anxiety disor-
ders. ❏
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Tratamientos no farmacológicos para los
trastornos de ansiedad
Se presenta una revisión basada en la evidencia de
los tratamientos no farmacológicos para los tras-
tornos de ansiedad. Gran parte de la investigación
controlada está dedicada a la terapia cognitivo con-
ductual (TCC) y muestra su eficiencia y eficacia en
los meta-análisis para todos los trastornos de ansie-
dad de la IV Edición del Manual Diagnóstico y
Estadístico de los Trastornos Mentales (DSM-IV). En
unos pocos estudios controlados se ha examinado
la relajación, las terapias psicoanalíticas, la terapia
Rogeriana no directiva, la hipnoterapia y la terapia
de apoyo, lo que impide cualquier conclusión defi-
nitiva acerca de su eficacia en fobias específicas,
agorafobia, trastorno de pánico, trastorno obsesivo
compulsivo (TOC) o trastorno por estrés postrau-
mático (TEPT). La TCC fue claramente mejor que la
terapia psicoanalítica para el trastorno de ansiedad
generalizado (TAG) y para la angustia de rendi-
miento. El debriefing psicológico para el TEPT
resultó perjudicial para los pacientes en un meta-
análisis de alta calidad. Estudios no controlados de
técnicas de psico-cirugía para el TOC intratable
demostraron un éxito limitado y efectos laterales
indeseables. Se obtuvieron resultados similares para
la simpatectomía en la ereutofobia. La neuroesti-
mulación transcraneal para el TOC está en una fase
preliminar de estudio. Se discuten los problemas
teóricos y prácticos de la propagación de la TCC.
Traitements non pharmacologiques des
troubles anxieux
Il est présenté ici une revue basée sur les preuves
des traitements non pharmacologiques des troubles
anxieux. La grande majorité de la recherche contrô-
lée est consacrée à la thérapie cognitivocomporte-
mentale (TCC) et des métaanalyses on montré la
pertinence et l'efficacité de cette thérapie dans tous
les troubles anxieux du Manuel diagnostique et sta-
tistique des troubles mentaux (DSM-IV). La relaxa-
tion, les thérapies psychoanalytiques, la thérapie
non directive dite de « Rogers », l’hypnothérapie,
et les thérapies de soutien ont été examinés dans
quelques études contrôlées, qui écartent toute
conclusion définitive sur leur efficacité dans les
diverses formes de phobie, l’agoraphobie, le
trouble panique, le trouble obsessionnel compulsif
(TOC), et l’état de stress posttraumatique (ESPT). La
TCC était manifestement plus efficace que le trai-
tement psychanalytique dans les troubles anxieux
généralisés (TAG) et l’anxiété de performance. Le
« debriefing » psychologique pour l’ESPT est apparu
dommageable aux patients dans une métaanalyse
de haute qualité. Des études non contrôlées des
techniques de psychochirurgie pour les TOC rebelles
ont démontré un succès limité et des effets secon-
daires fâcheux. Idem pour la sympathectomie dans
l’éreuthophobie. La neurostimulation transcrâ-
nienne pour les TOC a fait l’objet d’études prélimi-
naires. Les problèmes théoriques et pratiques pour
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